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Abnormally high deposition of iron can contribute to neurodegenerative disorders with 
cognitive impairment. Since previous studies investigating cognition-brain iron accumulation 
relationships focused on elderly people our aim was to explore the association between iron 
concentration in subcortical nuclei and two types of memory performances in a healthy young 
population. Gender difference was found only in the globus pallidus. Our results showed that 
iron load characterized by R2* value on the MRI in the caudate and putamen was related to 
visual memory, while verbal memory was unrelated to iron concentration.  
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Iron is considered to play a major role in many biological processes in the central nervous 
system. It is primarily located in subcortical brain regions, basal ganglia, cerebellar nuclei and 
hippocampi [1]. Pathological iron accumulation can contribute to numerous neurological 
disorders, including Alzheimer’s (AD), Parkinson’s, Huntington’s disease, dementia with 
Lewy Bodies, focal cervical distonia and multiple sclerosis [2–8]. Pathological studies of 
patients with AD revealed that excessive iron accumulation can contribute to the formation of 
free radicals, which can result in cell death and cell membrane damage [9,10]. 
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 Quantitative magnetic resonance imaging (MRI) techniques, such as mapping of the 
R2* relaxation rate (1/T2*), represent an indirect measure of iron which is a sensible and 
reproducible measure of tissue iron content [11–15].  
 Only few studies investigated the association between brain iron and cognitive 
performance in nondemented adults [7,15,17]. The major drawback of all these studies is that 
they include middle- and old-aged subjects, whilst neurodegenerative disorders can be present 
in these age groups with a high likelihood even without clinical signs. To our knowledge, no 
studies have investigated the relationship between iron concentration and cognitive 
performance in healthy young adults. Here our aim was to explore the association between 





Fifty-nine healthy university students (26 males) aged between 18 and 30 (mean ± SD: 22.5  ± 
2.4 years) were included. Subjects with chronic illnesses, neurological or psychiatric disorders 
were not included. Subjects underwent MRI measurements, cognitive testing assessing verbal 
memory, visual memory, and intelligence. According to the Wechsler Intelligence Scale mean 
IQ score was 123.7 (SD=7.0, min=110, max=138).     
The study was approved by the local ethical committee and all subjects gave written informed 
consent.  
 
Rey-Osterrieth Complex Figure Test 
The Rey-Osterrieth complex figure (ROCF) test is widely used in clinical and research 
settings to assess non-verbal visuoperceptual and visual memory [18,19]. To perform the 
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ROCF, a figure was placed in front of the subject, who was requested to copy the figure as 
accurately as possible. After a 30-minute delay, subjects were asked to reproduce the figure 
from memory without forewarning. Scoring followed the procedure described in the original 
manual [20]. 
 Since nearly all of the participants reached maximum scores on direct copying task 
only the scores of delayed recall were analyzed in our study.    
 
Rey Auditory-Verbal Learning Test 
The Rey Auditory-Verbal Learning Test (RAVLT) measures short-term verbal memory and 
verbal learning [21]. A list of 15 substantives (list A) is read aloud to the subject five 
consecutive times. Each of the attempts was followed by a test of spontaneous retrieval. After 
the fifth attempt, a list of interference, also comprising 15 substantives (list B) was read to the 
subject, followed by its retrieval. After attempt B1, the examiner asked the individual to recall 
the words from list A, without reading it again. After a 30-minute interval, the examiner asked 
the individual to remember the words from list A (Trial A7) without reading this list. 
Only the scores of the Trial 7 ‒ the number of correctly recalled words after the 30-minute 
interval ‒ were analyzed in the study.  
 
Magnetic resonance imaging and data analysis 
All measurements were performed on a 3T Siemens MAGNETOM Trio MRI scanner with a 
12-channel head coil. 
For R2* mapping, a multi-echo 3D FLASH sequence with 12 equally spaced echoes 
(TR/TE1=47/3.58ms; inter-echo spacing=3.53ms; Flip Angle=16°; 104 axial slices; slice 
thickness=1mm; FOV=208x256mm2; matrix size=208x256; receiver 
bandwidth=300Hz/pixel) was used. The shortest echo time was limited by the resolution 
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selected, while the longest one was chosen based on the expected T2* of the deep gray matter 
structures [22]. For tissue segmentation and registration, a T1-weighted 3D magnetization-
prepared rapid gradient echo (MPRAGE) sequence was utilized using the following 
parameters: TR/TI/TE=2530/1100/3.37ms; Flip Angle=7°; 176 sagittal slices; slice 
thickness=1mm; FOV=256x256mm2; matrix size=256x256; receiver 
bandwidth=200Hz/pixel. 
Four deep gray matter structures (left and right thalamus, caudate, putamen and globus 
pallidus) were segmented automatically on T1-weighted MPRAGE images using FIRST [23]. 
The quality of segmentations was visually checked for all participants. 
R2* maps were calculated by voxel-wise nonlinear least-squares fitting of the mono-
exponential signal decay over echo time (i.e. STE=S0·e-TE·R2*, where STE is the measured signal 
intensity at time TE and S0·is a constant) using Matlab (MathWorks, Natick, MA). 
In order to derive R2* values of the deep gray matter structures, R2* map of each 
subject was linearly registered to that subject’s MPRAGE image (6 degrees-of-freedom linear 
fit) using FLIRT [24]. Finally, the inverse of the spatial transformation from R2* map to 
MPRAGE space was applied to align the segmented brain masks to R2* map space, where 
R2* values were obtained. 
The resulting masks were eroded by using a 3D kernel of 3x3x3 voxels to avoid partial 
volume effects and to minimize possible impacts of misregistration between R2* maps and 
MPRAGE images. R2* values were calculated for the eroded deep gray matter structures and 
obtained separately for both the left and the right sides of the structures (Fig. 1). Finally, mean 
R2* values were calculated for each deep gray matter structure by averaging the means from 
the left and right hemispheres. 
An internal white matter reference was added to the figures (for more details see [25]). 
A free-hand region of interest (ROI) was drawn in the left centrum semiovale on a given axial 
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slice of MNI152 standard-space 1 mm T1-weighted average structural template image 
(Supplementary material 1). In order to derive R2* values of this ROI, the MNI152 standard-
space image was linearly registered to R2* map of each subject using FLIRT. Then the spatial 
transformation from MNI standard-space to R2* map was applied to align the ROI to R2* 
map space, where R2* values were obtained. Finally, R2* values were calculated for each 
individual separately.  
 
------------------------------ 




Each variable was tested for normality using Kolmogorov–Smirnov test, only age deviated 
significantly from normal distribution. Gender differences were assessed by using 
independent samples t-tests. Age deviated significantly from normal distribution, therefore the 
associations between age and R2* values were tested using nonparametric Spearman 
correlation analyses.  Some previous studies showed that age and gender significantly 
correlate with R2* values [1,5,7,26]. Therefore, we controlled for the effect of age and gender 
in separate multiple linear regression models, in which R2* values were used as the 
independent and cognitive parameters were used as dependent variables. The assumptions of 
linear regressions were satisfied, as judged by testing for linearity, normality assumptions of 
the residues, outliers, independence of errors, homoscedasticity, and multi-collinearity [27]. 
Data analysis was performed using SPSS statistical software ® version 22.0 (IBM Corp. 





Significant gender difference was found in the globus pallidus and centrum semiovale. 
According to the independent samples t-tests females showed higher R2* values in the globus 
pallidus and smaller in the centrum semiovale (Table 1.). Age was positively correlated with 
R2* values in the thalamus, caudate and putamen (Supplementary material 2).  
Cognitive scores showed no gender differences. The mean score (SD) in the ROCF was 22.65 
(6.63) in males and 23.91 (6.31) in females. The mean score (SD) in the RAVLT was 12.77 
(2.32) in males and 13.33 (1.85) in females.    
 
------------------------------ 
Table 1 insert here 
------------------------------ 
 
Multivariate analyses controlling for age and gender 
R2* variables and cognitive parameters were used in multivariate analyses to control for age 
and gender (Fig. 2). In this analysis the associations between visual memory and R2* values 
were significant in the caudate (ß = -.313, 95% CI -3.065, -.044, p = .044) and putamen (ß = -
.326, 95% CI -2.356, -.013, p = .048), whilst R2* values in the thalamus and globus pallidus 
showed no significant relationships. 
Verbal memory was unrelated to R2* values in deep gray matter structures.  
 
------------------------------ 




As far as we know, this is the first study examining the relationship between cognitive 
performance and brain iron content as assessed by R2* values and in healthy young adults. 
Our main findings are that iron loads in the caudate and putamen were related to visual 
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memory independently of the age-related iron increase. However, verbal memory was 
unrelated to iron concentration. In accordance with some previous findings iron accumulation 
significantly increased with age in the thalamus, caudate, putamen [26,28,29] and the pattern 
of mean R2* values was similar to those observed in previous researches (e.g. highest level in 
the pallidum) [30–32]. These similarities suggest that the differences in our study were also 
related to iron concentration and not to other factors, such as other minerals. However, since 
mean iron concentration in brain structures is strongly connected to age, and to our knowledge 
this is the first study investigating young sample (with mean age of 22.5) it is difficult to 
compare our results to previous findings. 
 Iron concentration in healthy young individuals with normal cognitive profile have so 
far been neglected in the literature. Our data showed moderate positive associations with age, 
particularly in the putamen, thalamus and caudate. These findings are consistent with studies 
focusing on elderly people or patients with neurodegenerative disorders [1,28,33] and 
emphasize that age related increase in the iron content of brain tissues is the most remarkable 
in earlier life stage [34]. However several MRI imaging methods were found to strongly 
correlate with age and postmortem cortical iron staining (including phase imaging, R2 
mapping, T2 weighting and Field-dependent R2 Increase), R2*, that was used in our study 
appears to be the most reliable and least time-consuming method according to some previous 
studies [8,35,36]. 
In this study, we found associations between R2* values in deep gray matter structures 
and visual memory in healthy young adults with normal cognitive profile. Our results are in 
accordance with several previous findings performed in elderly. Penke et al. [17] found a 
negative association between iron deposition at age 72 and general cognitive ability at age 11, 
implicating that early life general cognitive ability leads to important lifestyle differences that 
influence the amount of iron in the brain on later life periods. Supporting evidence comes 
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from a longitudinal study of Lozoff and colleagues [37]. They found that children who 
received iron-fortified formula as infants had worse cognitive scores at 10 years than those 
receiving low-iron formula. The test scores were also associated with hemoglobin level 
showing better cognitive performance in low hemoglobin group. Our study is also in 
agreement with the earlier reports of associations of cognitive tasks with iron, although the 
pattern of related cognitive skills and brain structures are inconsistent [16,38–41]. These 
results including our findings, suggest that brain iron accumulation is in correlation with 
cognitive performance in all ages.  
One possible, but highly speculative explanation indicates the role of brain iron 
concentration as a marker of AD. Some clinical studies tried to find when the neuropathology 
of AD begins and if there are any reliable early markers of the disease. Borenstein et al. [42] 
reviewed the topic and suggested that several risk factors are present in AD and it is best to 
consider it in a life-course framework. One of these potential risk factors is the reduced 
cognitive and intellectual reserve [43]. The study of Fox and colleagues [44] also 
demonstrates that memory loss in AD is detectable years before symptoms appear. However, 
studies regarding iron accumulation are even sparser, only one study was found. In that paper, 
Bartzokis et al. [45] found no correlation between the length of illness and iron levels in basal 
ganglia, suggesting that iron increase in AD is not caused by the illness, rather it might be 
interpreted as a risk factor for the disease. They also found that iron levels in the putamen, 
globus pallidus and caudate are the most prominent in patients with young-onset AD 
(age<70).  Data from these observational studies suggest that brain iron accumulation may be 
a risk factor in developing AD. More studies are needed to explore the mechanism of this 
potential association.    
The findings reported here should be interpreted in the context of the study limitations. 
First, R2* is a reliable but not a specific measure of iron in brain tissues, R2* values can be 
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influenced by other elements, such as calcium [46]. Second, our study focused only on visual 
and verbal memory performance. Future studies with more extended assessments and 
longitudinal design are needed to get clearer picture about the affected cognitive domains. 
Third, R2* data regarding hippocampus were not used in this study although it plays crucial 
role in memory functions. The reason is that hippocampus is a complex anatomical region 
which is difficult to study with R2* due to partial volume effects and due to susceptibility 
effects from the temporal bone and nearby air–tissue interfaces [47].  
However, it is well known that the pathophysiological process of AD begins decades 
before the diagnosis [48] and the development of early biomarkers that detect asymptomatic 
AD became a priority but there is still a need to find new paths to determine them [49]. We 
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Brain regions median (IQR) (male) 
median (IQR) 
(female) 
Gender differences Age 
   t Spearman’s rho 
Thalamus 19.30 (1.25) 19.41 (1.31) -.302 .316* 
Caudate  18.72 (1.17) 19.34 (1.74) -.493 .439** 
Putamen 20.78 (2.02) 21.37 (2.74) -.141 .515** 
Globus pallidus 33.09 (4.33) 34.65 (4.69) -2.098* .120 
Centrum 
semiovale 
18.8 (1.55) 18.2 (1.09) 2.539* -.025 
 
Table 1. Median, gender- and age-effects on iron levels. One asterisk denotes p < .05, two 








Figure 1. A representative image of deep grey matter structures (cyan – left thalamus, yellow 
– right thalamus, pink – left globus pallidus, green – right globus pallidus, blue – left 





Figure 2. Scatterplots representing the relationships between performance on memory tasks 
and iron content in deep gray matter structures and Centrum Semiovale (control region). The 



















Supplementary material 1. An internal white matter reference to the figures. A free-hand 
region of interest (ROI) was drawn in the left centrum semiovale on a given axial slice of 





Supplementary material 2. Scatterplots representing the relationships between age and iron 
content in deep gray matter structures and Centrum Semiovale (control region). The 
Spearman correlations in the thalamus, caudate and putamen were significant. 
 
